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ABSTRACT
Introduction: A need exists for sustainable and
clinically effective weight management interventions,
suitable for preventing well-linked chronic disease such
as diabetes and cardiovascular disease and some less
investigated secondary conditions such as bone
alteration. The ADIposity and BOne metabolism: effects
of eXercise-induced weight loss in obese adolescents
(ADIBOX) protocol was designed to provide a better
understanding of the interaction between adipokines
and bone hormones in adolescents with obesity and
how a 10-month physical activity programme may
affect these interactions.
Methods and analysis: The ADIBOX protocol
combines 2 studies. The first study involves a total of
68 adolescents aged 12–16 years. This cross-sectional
study will include both males and females (1:1 ratio),
either living with obesity/overweight (n=34; body
mass index (BMI) ≤97th centile and ≥85th centile) or
normal weight (n=34; BMI<85th centile). The second
study is a longitudinal study that will include 50
obese adolescent girls and track them over a period
of 42 weeks. Weight loss programme will consist of a
combination of physical activity and a normocaloric
diet. Bone and adiposity-related measurements will
be performed every 14 weeks. Both studies will
assess participants’ anthropometric profile, nutrition
and physical activity, body composition, bone
densitometry and blood markers of bone, growth
and adiposity.
Ethics and dissemination: The ADIBOX protocol
complies with the ethics guidelines for clinical
research and has been approved by their respective
ethics committee (Australian Catholic University
Committee Ethic, Australia and Hospital Sud Est 1
committee, France). Findings from this protocol are
expected to clarify the possible interactions
between adiposity and bone in childhood obesity and
will be disseminated at several research conferences
and published articles in peer-reviewed journals.
Trial registration number: NCT02626273;
Pre-results.
INTRODUCTION
The complex consequences of childhood
obesity represent major concerns in most
developed countries,1 largely contributing to
metabolic complications with costly repercus-
sions for the burden of disease.2 3 This
burden is exempliﬁed by high prevalence
rates of overweight or obesity. For instance,
in Australia the prevalence of overweight and
obesity is 24% in boys and 23% in girls, while
in France the prevalence is 20% of boys and
16% of girls.4
Understanding the effects of obesity-
induced fat mass accumulation on bone
during growth is of particular interest given
that obesity is a risk factor for fracture
during the peripubertal period.5 Childhood
and adolescence are characterised by signiﬁ-
cant bone accrual. The achievement of
optimal skeletal gains throughout the matur-
ation process is crucial in order to optimise
bone mass before adulthood. However, the
levels of some circulating hormones, either
dependent or independent of fat mass, vary
widely from childhood to puberty and adult-
hood and may subsequently strongly affect
bone density.
Strengths and limitations of this study
▪ Advancing the understanding of the bone adipo-
cyte cross-talk in obese adolescents.
▪ Investigating the effects of physical activity-
induced weight loss on bone, growth and adi-
posity markers.
▪ Longitudinal study only assessing female
adolescents.
▪ Unable to accurately account for the different
phases of the female menstrual cycle.
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Owing to their common origin, bone cells and adipo-
cytes are intimately associated, suggesting a cross-talk
between adipose tissue and bone tissue. Adipose tissue
has long been considered an inert tissue dedicated for
energy storage. Recent advances have established that
both adipose tissue and bone tissue are endocrine
organs. Adipose tissue is involved in satiety, energy
balance and pubertal development,6 while bone tissue
acts on energy expenditure and glucose homoeostasis.7
The impact of obesity on bone metabolism is gaining
the attention of researchers. The skeletal system is stressed
from mechanical loading and also through the metabolic
effect of some of the adipokines secreted by the adipose
tissue. Indeed, obesity leads to hormonal alterations asso-
ciated with increasing proinﬂammatory cytokines and oxi-
dative stress. These events favour the accumulation of fat
mass and loss of bone mass. Moreover, weight loss induced
by dietary restriction can lead to weakening bones.8
Decreased mechanical loading on the skeleton,9 altered
hormonal secretion involved in bone regulation10 or
decrease of caloric intake9 may contribute to the bone
breakdown generated by weight loss strategies during
childhood. However, weight bearing physical activity may
be anabolic for bone, even during periods of weight loss.
A better understanding of the effects of weight loss
programmes on the bone adipocyte cross-talk in adoles-
cents is required in order to prescribe effective and safe
weight loss programmes. As previously shown, the effect-
iveness of weight loss programmes for improving the
overall health in obese youth may be compromised by
potential side effects (ie, loss of bone mass).
Our team recently justiﬁed the need of further investi-
gations exploring the bone adiposity cross-talk in adoles-
cents with obesity.11 Fat and bone are linked by multiple
possible interactions but the low volume and inconsist-
ent methodologies of existing studies prevent strong
conclusions about the presence of deﬁnitive relation-
ship. A speciﬁc project is required to advance the under-
standing of the complex relationship between fat mass
and bone mass in adolescents with obesity.
The overall purpose of this work is to investigate the
effects of body mass and its variations (taking into
account body composition) on the bone adipocyte cross-
talk in adolescents with obesity. To do so, a cross-
sectional and a longitudinal study will be conducted.
The ADIposity and BOne metabolism: effects of
eXercise-induced weight loss in obese adolescents
(ADIBOX) protocol will contribute to the evidence
required to promote the holistic signiﬁcance of sustain-
able weight management in obese youth.
METHODS AND ANALYSIS
Cross-sectional study—study I
Protocol design
This study will investigate whether the interaction
between adipokines and bone hormones differ between
obese and their normal weight peers (ﬁgure 1).
Selection criteria
Adolescents aged between 12 and 16 years, over Tanner
stage 3, free of any recent history of hospitalisation (past
2 years) or of systemic illness lasting more than 2 weeks
in the past 12 months will be recruited. In compliance
with Human Ethics guidelines, adolescents and their
legal representatives will sign assent and consent forms,
respectively. Also, the recruited adolescents will not have
any known history of metabolic bone or muscle disease,
nor metabolic diseases such as diabetes, insulin resistance,
or hypothyroid or hyperthyroid activity.
Additional inclusion criteria relate to being free from
a diagnosis of congenital cardiovascular disease, not
regularly consuming alcohol, being a non-smoker and
not taking medication known to alter bone metabolism,
nor hormones or calcium preparations (vitamin D,
calcium, protein). Owing to the low exposure to radi-
ation, women will be excluded if they are pregnant and
will need to have a regular menstrual cycle. Obese men
and women recruited for this study will have a body
mass index (BMI) ≥95th centile.12 Furthermore, adoles-
cents who are overweight or with obesity will be ineli-
gible if they were enrolled in a weight management
programme during thepast 2 years.
Age-matched and gender-matched normal weight par-
ticipants (BMI<85th centile)12 will also be recruited. If
necessary, in order to include a sufﬁcient number of
participants, we will consider recruiting both obese and
overweight (BMI≥85th centile) adolescents. Normal
weight, overweight and obese adolescents will be
excluded if they participate in more than 250 min of
physical activity outside of school per week. The 250 min
was derived by excluding the physical education and
school sport from guidelines recommending 60 min per
day or 420 min per week.13 This ensured that none of
the participants exceeded the recommended guidelines
for physical activity. Minutes of weekly physical activity
will be monitored during the screening visit using the
International Physical Activity Questionnaire (IPAQ).
Power analysis
Owing to a lack of data and reported discrepancies in
the literature it seemed difﬁcult to propose an a priori
accurate sample size estimation. The number of partici-
pants to be included in the study has been extrapolated
from the data obtained on previous works.14 For a
two-side type I error at 5% and a statistical power equiva-
lent to 80%, 17 participants of each sex per group of
obese and lean body composition status (a total of 68
participants) will allow us to highlight a clinical and real-
istic effects size of 1 SD between groups in key obesity
outcomes.15
Participants
As previously stated participants engaged in this protocol
will be adolescents aged between 12 and 16 years, with a
self-reported pubertal development status equal to or
exceeds Tanner stage 3. Differences in race and
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ethnicity of participants will be accepted. The adolescent
stage of development was selected to advance the under-
standing of maturation processes, growth changes and
the possible exploratory aspects of weight changes. For
this study, we will recruit both male and female adoles-
cents who are obese or overweight (1:1 ratio) as well as
their age-matched and sex-matched lean peers. The
non-obese group is necessary for a better understanding
of the hormonal changes induced by obesity.
Participant recruitment
Following approval from ethic committees, and based
on our calculation, a total of 68 adolescents, men and
women will be enrolled in the ﬁrst study of the ADIBOX
protocol. All participants as well as their legal represen-
tatives will be given written information regarding the
project and be asked to sign consent and assent forms.
Adolescents will be recruited from medical clinics in
Melbourne and Sydney, Australia, and from the
Australian Catholic University (Victoria or New South
Wales—Australia) using the ‘snowballing’ principle. The
68 adolescents will be split into two groups of 34 each;
a non-obese group and an obese/overweight group.
Groups will comprise 17 men and 17 women, in order
to understand more about sex-based comparisons.
Measurements
After a screening visit to ensure the suitability of adoles-
cents to complete the study, each adolescent will
perform a battery of tests. Data collection will be per-
formed only once (ﬁgure 2).
Ability to complete the study
The researcher will make a phone call prior to the
beginning of the study to ensure the suitability of adoles-
cents to complete it. If the participant is willing to par-
ticipate, general information such as medical history of
the family, early childhood development and history of
obesity will be gathered during this phone call.
Maturation
Pubertal status will be assessed using the Tanner’s Stage
of Pubertal Development model for biological
Figure 1 ADIBOX protocol.
ADIBOX, ADIposity and BOne
metabolism: effects of
eXercise-induced weight loss in
obese adolescents; CS,
cross-sectional study; LG,
longitudinal study.
Figure 2 ADIBOX protocol overview. ADIBOX, ADIposity
and BOne metabolism: effects of eXercise-induced weight
loss in obese adolescents; DXA, dual energy X ray
absorptiometry; PA, physical activity; pQCT, peripheral
quantitative CT; QUS, quantitative ultrasound.
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maturation. An experienced researcher will be provided
with a series of pictures showing the ﬁve stages of
puberty for breast or genitalia and pubic hair develop-
ment.16 Despite the fact that self-reported maturation
stages is less precise than a paediatric assessment it still
has a good validity and reliability.17
Anthropometry
Anthropometric measurements will be taken accordin-
gly to the anthropometrics recommendations of the
International Society for the Advancement of
Kinanthropometry for standing height (m) and body
mass (kg), waist circumference (cm), and lower limb
bone lengths/breadths (cm).18
Physical activity and nutrition questionnaires
Among participants, validated sedentary activity19 and
physical activity questionnaires (IPAQ)20 will be distributed
to assess physical activity. In addition, a food freq-
uency questionnaire,21 current eating habits question-
naire22 and a food preferences questionnaire23 will be
distributed.
Body composition
Body composition will be measured by dual energy X ray
absorptiometry (DXA) (DXA, iDXA, GE healthcare,
Lunar Corporation, Madison, Wisconsin, USA). Bone
mineral density (BMD, g/cm2), bone mineral content
(BMC, g), bone area (cm2), and lean and fat mass (sub-
cutaneous and visceral) will be determined for each ado-
lescent. The DXA measurements will be taken for the
whole body, lumbar spine (L2–L4) and the non-
dominant hip (including the femoral neck, trochanteric
and intertrochanteric regions). All DXA scans will be con-
ducted by the same technician and quality assurance
checks will be performed routinely. This scanning proto-
col and ofﬂine analyses have been validated among com-
parable population.24
Peripheral Quantitative CT
Musculoskeletal parameters for bone geometry includ-
ing bone strength will be obtained using a peripheral
quantitative CT (pQCT) XCT 2000 in study I (XCT
2000, Stratec Medizintechnik, Pforzheim, Germany).
BMC (g/cm), volumetric cortical and trabecular BMC
(mg/cm3), total area (mm2), cortical and trabecular
area (mm2) and density (g/cm²), bone strength (mm3)
will be assessed at the distal (4%), proximal (66%) site
of the non-dominant tibia and radius. A planar scout
scan was ﬁrst conducted to determine the anatomical
reference line for the radius and tibia. Tomographic
slices of 1 mm thickness were obtained at the 4% and
66% sites measured distally. Scan speed and voxel size
were 30 mm/s and 0.5 mm, respectively. To assure
quality of measurement, calibration checks will be per-
formed by scanning a standard phantom with known
densities, prior to each scan.
In order to calculate BMC, volumetric cortical BMC,
volumetric trabecular BMC, cortical area (CoA), cortical
density (CoD), trabecular area (TrA), trabecular density
(TrD) and stress–strain index (SSI) will be analysed with
Stratec pQCT software. Contour mode 1 with a threshold
of 180 mg/cm3 was used to separate soft tissue and bone
in order to analyse trabecular bone. Cortical bone was
identiﬁed and removed using a constant default thresh-
old of 710 mg/cm3. A contour mode 3 with peel mode
1 at a threshold of 40 mg/cm3 was used to assess muscle
and fat cross-sectional area. Radial distribution and
polar density will be estimated with an open source
bone image analysis tool, known as Image J (rsbweb.nih.
gov/ij). To differentiate the cortical bone a threshold of
710 mg/cm3 and a 3×3 median ﬁltering of the image
was used. For mean cortical polar bone mass distribution
and polar distribution the cortex is divided into equal
sectors, while the 66% slice radial distribution will be
estimated by subdividing the cortex into concentric
rings. For more information, this open source software
was validated and described in two studies of
Rantalainen et al.25 26
Endocrine assays
Blood samples will be collected by a qualiﬁed paediatric
nurse after the participants have fasted overnight. Blood
will be collected by a venipuncture at the brachial vein.
After collection, blood will be centrifuged and aliquots
will be stored (-80°) for subsequent analysis.
Basic biology (triglycerides (TG), cholesterol, low-
density lipoprotein (LDL), high-density lipoprotein chol-
esterol (HDLC), glycaemia, insulin, ultrasensible C react-
ive protein (CRP)) will be assessed in the biochemistry
laboratory of the Australian Catholic University (Sydney,
Australia). Bone markers will be assayed in
the biochemistry laboratory of the Sydney University
(Sydney, Australia): serum osteoprotegerin (OPG), recep-
tor activator of nuclear κB ligand (RANKL), sclerostin,
bone alkaline phosphatase and undercarboxylated osteo-
calcin (unOc) will be assayed using ELISA kits while type
I collagen C-telopeptides (CTX), PINP, osteocalcin total
and vitamin D by Cobas 6000 (Roche Diagnostics).
All other biochemical determination (leptin, adipo-
nectin, tumour necrosis factor (TNF)-α, interleukin
(IL)-6, growth hormone (GH), insulin-like growth
factor-1 (IGF1), insulin-like growth factor-binding
protein 3 (IGFBP-3), oestradiol, follicle stimulating
hormone/luteinizing hormone (FSH/LH) and
parathyroïd hormone (PTH)/calcitonin) will be made
using commercial kits, following manufacturers’ recom-
mendations, including sampling steps, allowing the best
performances of coefﬁcient of variation and sensitivity.
All analyses will be conducted in duplicate by the same
technician.
Statistical analysis
Data will be analysed using Stata (StataCorp, College
Station, Texas, USA) and signiﬁcance will be accepted at
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a two-sided α level of p<0.05. After testing for normal
distribution (Shapiro-Wilk test), data will be treated
either by parametric or non-parametric analyses accord-
ing to statistical assumptions. Means and SDs will be
reported for descriptive statistics and used to summarise
the data. In case of non-Gaussian distribution, median
and IQR will be reported. For general linear model
(GLM) or multilevel model, the data will be log trans-
formed or Box-Cox transformed, where appropriate.
Group comparisons will be assessed using analysis of
covariance (ANCOVA) to compare quantitative para-
meters between obese and lean adolescents, as well as for
gender comparison after controlling for pubertal status.
Ethical considerations and dissemination
The cross-sectional study has been approved by the
Australian Catholic University Ethic Committee (2014
320N). In accordance with ethical considerations, the
principal investigator is responsible of ensuring that par-
ticipants understand the potential risks and beneﬁts of
taking part in the study. Moreover, the principal investi-
gator is responsible for obtaining a written consent from
adolescents and their legal guardians/parents.
Ten-month longitudinal study—study II
Protocol design
This 42-week longitudinal study with repeated measures
on four occasions (baseline and thereafter every
14 weeks) will allow us to understand the effect of phys-
ical activity-induced weight loss on the bone adipocyte
cross-talk in obese adolescent females (ﬁgure 1). For
this study, we will compare two groups of obese adoles-
cents: one following a residential weight loss programme
and compare their results to a group not receiving any
intervention or advice for weight loss.
Selection criteria
Similarly to the cross-sectional study, obese females
(BMI>95th centile)12 who are invited to take part in this
study will be aged between 12 and 16 years, with a self-
reported pubertal status equal to or exceeding Tanner
stage 3, free of any recent history of hospitalisation (past
2 years) or of systemic illness lasting more than 2 weeks
in the past 12 months. In compliance with Human
Ethics guidelines, adolescents and their legal representa-
tives will sign assent and consent forms, respectively, and
will have to be covered by social health insurance.
Also, the recruited adolescents will need to have no
limitations to being physically active and will not have a
known history of metabolic bone or muscle disease, nor
metabolic diseases such as diabetes, insulin resistance or
hypothyroid or hyperthyroid activity. Additional inclu-
sion criteria relate to being free from a diagnosis of con-
genital cardiovascular disease, not regularly consuming
alcohol, being a non-smoker and not taking medication
known to alter bone metabolism, nor hormones or
calcium preparations (vitamin D, calcium, protein).
Owing to the low exposure to radiation, women will be
excluded if they are pregnant and will need to have a
regular menstrual cycle.
Exclusion criteria
Adolescents will be excluded if major treatment and/or
protocol deviations are observed by the obesity centre
team. In addition, they will be excluded and not consid-
ered in the analysis if their compliance to the pro-
gramme is <80%. This threshold has been chosen based
on our previous experience27 and the fact that adoles-
cents are integrated as a speciﬁc institution.
Power analysis
Sample size estimation has been set within the context
of the variation index of body fat relative to the variation
of a marker of bone mass measured at the lumbar spine.
Currently, few articles provide information about the
combined effects of body fat and lumbar spine para-
meters in the literature. However, based on limited pre-
vious research28 the index difference of the variation
index of body fat, relative to the variation of a marker of
bone mass at lumbar spine between groups, of 1.2–1.5
(SDs) can be expected. It seemed reasonable to set the
variation index at 1.3 (SDs). Based on this, a sample size
of 21 female participants was predicted to highlight statis-
tically signiﬁcant differences with a statistical power of
90% and a two-sided type I error less of 5%. Anticipating
a potential 20% drop-out among participants, a minimum
of 25 volunteers per body composition group will be
invited to take part in the study.
Participants
As previously stated participants in this second study will
be adolescents aged between 12 and 16 years, with a
paediatrician-assessed maturation stage equal to or
exceeding Tanner stage 3. The adolescent stage of devel-
opment was selected to advance the understanding of
maturation processes, growth changes and the possible
exploratory aspects of weight changes. Race and ethni-
city of participant is mixed.
As the obesity centre that our study group is associated
with is hosting only women, we will restrict recruitment
to adolescent women. The community dwelling control
group with obesity is necessary in this study to provide
useful information on setting the effects of exercise-
inducing weight loss on the bone adipocyte cross-talk.
Participant recruitment
Following approval from ethic committees, and based
on our calculations, a total of 50 adolescents’ girls will
be enrolled for the second study of the ADIBOX proto-
col. All participants as well as their legal representatives
will be given written information regarding the project.
Both the adolescents and their legal guardians will have
to sign consent forms before enrolment of the adoles-
cent. Adolescents will be recruited from the ‘Tza Nou’
Medical Center for Children and the SSR (ambulatory
care and rehabilitation department) Nutrition-Obesity
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in Auvergne (France). The participants will be divided
into two groups on a convenient basis: an intervention
group (25 obese women from ‘Tza Nou’—France) who
will undertake the residential programme and an obese
control group (25 obese women from the SSR
Nutrition-Obesity—France) who will remain with their
family and in a community setting.
Institution programme
Adolescents from the intervention group will be
enrolled at the obesity centre for the whole school year
(ie, 10 months). The obesity centre employs a multidis-
ciplinary team to provide the best weight management
care to adolescents during their stay. The weight loss
programme is an integral part of the obesity centre pro-
gramme and fundamentally combines physical activity
with a normocaloric diet monitored by a dietician. The
physical activity programme consists of two training ses-
sions (aerobic and resistance training) per week.
Moreover, adolescents will be engaged in two additional
sessions per week, consisting in recreational activities
such as ball and racquet games, trekking, snowshoeing
or swimming.
Measurements
After a screening visit to ensure the suitability of adoles-
cents to complete the group in the study to which they
have been assigned, each adolescent will perform a
battery of tests (described below). Data collection will be
performed four times for the 42-week longitudinal study.
Adolescents will be screened at baseline (T0) and there-
after every 14 weeks. This period of testing coincides
with school holidays and includes the bone remodelling
cycle period of 3 months (ﬁgure 2).
Ability to complete the study
A paediatrician will meet participants assigned to the
weight management group prior to the beginning of the
study to ensure the suitability of adolescent to complete
the weight loss protocol. If the participant is willing to
participate, general information such as medical history
of the family, early childhood development and history
of obesity will be gathered by the paediatrician.
Maturation
Pubertal status will be assessed by a paediatrician using
Tanner’s Stage of Pubertal Development model for bio-
logical maturation16 as well as laboratory blood analyses
(oestradiol, testosterone, FSH/LH). Information about
the age at menarche and regularity of menstruation will
be gathered by the paediatrician.
Anthropometry
Anthropometric measurements will be taken according
to the recommendations of the International Society for
the Advancement of Kinanthropometry for the follow-
ing: standing height (m) and body mass (kg), waist
circumference (cm), and lower limb bone length/
breadth (cm).18
Physical activity and nutrition questionnaires
Among participants, validated sedentary activity19 and
physical activity questionnaires (IPAQ)20 will be distribu-
ted to assess physical activity. In addition, a food fre-
quency questionnaire,21 current eating habits22 and food
preferences questionnaire23 will be distributed.
Body composition
Body composition will be measured by DXA (DXA,
QDR-4500A, Hologic, Waltham, Massachusetts, USA).
BMD (g/cm2), BMC (g), bone area (cm2), and lean
and fat mass (subcutaneous and visceral) will be deter-
mined for each adolescent. The DXA measurements will
be taken for whole the body, lumbar spine (L2–L4) and
the non-dominant hip (including the femoral neck, tro-
chanteric and intertrochanteric regions). All DXA scans
will be conducted by the same technician and quality
assurance checks will be performed routinely.
Peripheral quantitative CT
Similarly to the cross-sectional study, musculoskeletal
parameters for bone geometry including bone strength
will be obtained using the pQCT XCT 3000L (XCT
3000L, Stratec Medizintechnik, Pforzheim, Germany).
BMC (g/cm), volumetric cortical and trabecular BMC
(mg/cm3), total area (mm2), cortical and trabecular
area (mm2) and density (g/cm²), and bone strength
(mm3), will be assessed at the distal (4%) and the prox-
imal (66%) site of the non-dominant tibia and radius.
Pictures will be analysed with Stratec pQCT software and
Image J, an open source bone image analysis tool
(rsbweb.nih.gov/ij).25 26
Quantitative ultrasound
This method may provide additional information on
bone quality and architecture. To predict fracture risk,
quantitative ultrasound (QUS) measurements will be
made with Achilles Insight+ (Achilles Insight, GE, Lunar
Corporation, Madison, Wisconsin, USA) on the non-
dominant calcaneus. The QUS results will be expressed
in terms of broadband ultrasound attenuation (BUA,
dB/MHz) which is postulated to reﬂect bone mass and
architecture, and speed of sound (SOS, m/s) which is
estimated to reﬂect the mass and elasticity of bone. This
technique has been shown to be useful in child and ado-
lescent bone investigations.29 The in vivo coefﬁcient
of variation assessed in our laboratory for paediatric use
is 1.4% for BUA and 0.16% for SOS measurements.
All analyses will be conducted in duplicate by the same
observer.
Endocrine assays
Similarly to the cross-sectional study, blood samples will
be collected by a qualiﬁed paediatric nurse after the par-
ticipants have fasted overnight. Blood will be collected
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by a venipuncture at the brachial vein. After collection,
blood will be centrifuged and aliquots will be stored
(-80°) for subsequent analysis.
Basic biology (TG, cholesterol, LDL, HDLC, gly-
caemia, insulin, ultrasensible CRP) will be assessed in the
biochemistry laboratory of Clermont-Ferrand University
Hospital, while bone markers will be assayed in the bio-
chemistry laboratory of Montpellier University Hospital
(OPG, RANKL, sclerostin, bone alkaline phosphatase,
unOc, CTX, PINP, osteocalcin total and vitamin D).
All other biochemical determination (leptin, adiponec-
tin, TNF-a, IL-6, GH, IGF1, IGFBP-3, oestradiol, FSH/LH
and PTH/calcitonin) will be made using commercial
kits, following manufacturers’ recommendations, includ-
ing sampling steps, allowing the best performances of
coefﬁcient of variation and sensitivity. All analyses will be
conducted in duplicate by the same technician.
Energy metabolism
Routinely performed in our laboratory, resting metabol-
ism rate (RMR) is a reliable measure that reﬂects
muscle mass. RMR will be measured in the morning
using indirect calorimetry (K4b², Cosmed, Rome, Italy).
Before each test, gas analysis is calibrated in accordance
with the manufacturer’s recommendations. Participants
will be asked to lie in a supine position in a thermoneu-
tral environment (22–25°C room temperature) for
45 min before starting the measurements. After achiev-
ing a steady state, O2 consumption and CO2 production
standardised for temperature, barometric pressure and
humidity will be recorded at 1 min intervals for 20–
45 min and averaged over the whole measurement
period.
Compliance
Volunteers engaged in the residential arm of the longi-
tudinal study will be monitored by educators working at
the obesity centre in order to control for their daily
engagement and adherence to the weight loss lifestyle
intervention combining physical activity and nutrition
(normocaloric diet). Educators will complete an indivi-
dualised daily journal on the compliance of each
participant.
Statistical analysis
Data will be analysed using Stata and IBM Statistics
SPSS V.22 (IBM Corp, 2013, Chicago, Illinois, USA) and
signiﬁcance will be accepted at a two-sided α level of
p<0.05. After testing for normal distribution (Shapiro-
Wilk test), data will be treated either by parametric or
non-parametric analyses according to statistical assump-
tions. Means and SDs will be reported for descriptive
statistics and used to summarise the data. In case of
non-Gaussian distribution, median and IQR will be
reported. For a GLM or a multilevel model, the data will
be either log transformed or Box-Cox transformed,
where appropriate.
Student’s t-tests or Mann-Whitney U test (when
assumptions of t-test are not met: normal distribution
and homoscedasticity will be studied using the Fisher-
Snedecor test) will be performed to compare adipose
tissue (total, subcutaneous, visceral) variation reported
to bone mass variation at the lumbar spine between
groups at baseline. χ2 tests or the Fisher’s exact tests will
be used for categorical variables. Group comparisons
will be assessed using ANCOVA to compare quantitative
parameters between obese and non-obese adolescents,
as well as for gender comparisons after controlling for
pubertal status. Moreover, Pearson’s (or Spearman’s
when appropriate) correlation coefﬁcients will be used
and compared with the Fisher test (command corcor
Stata) to measure the potential links between
exercise-induced weight loss and changes in adipose
tissue and bone mass. Longitudinal data will be treated
using a mixed model analyses in order to treat
ﬁxed-effects group, time and group×time interactions
taking into account between and within participant vari-
ability. Moreover, the impact of covariates (ie, compli-
ance, BMI, hormonal status) will be explored. A
sensitivity analysis of missing data will be performed to
ensure the relevance of the longitudinal data (missing at
random or MCAR missing completely at random). In
order to assess the problem caused by missing longitu-
dinal data, estimation methods developed by Verbeke
and colleagues will be proposed.
Ethical considerations and dissemination
The longitudinal study has been registered with a clin-
ical trial number (NCT02626273). Ethics approval has
been obtained from the Hospital Sud Est 1 committee
(2015-33).
In accordance with ethical considerations, the princi-
pal investigator of each study is responsible for ensuring
that the participants understand the potential risks and
beneﬁts of taking part in the study. Moreover, the princi-
pal investigator is responsible for obtaining written
consent from the adolescents and their legal guardians/
parents.
Link between studies
The ADIBOX protocol combines two studies: a cross-
sectional study addressing gender and weight effects of
the bone adipocyte cross-talk while the longitudinal
study will focus on the effects of weight loss induced by
physical activity and nutrition in obese adolescents.
Since the actual literature remains unclear regarding
the interactions between adipocyte and osteocyte, both
studies appear necessary to advance the understanding
of these interactions in obesity and how they change
over time. As previously stated by our team11 only
limited and heterogeneous literature (ie, large hetero-
geneity: including gender, age, pubertal status, matura-
tions stage) is available to date for explaining the
inability to draw clear conclusions. Using the same
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methodology, our studies will provide complementary
approaches with transversal and longitudinal results.
Radiation
Both DXA and pQCT provide measures of body com-
position and bone properties by exposing participants to
low-level radiation: 0.0056 mSv from DXA scans (whole
body, lumbar and hip) and 0.0014 mSv from the pQCT
scans (tibia and radius measures).30 Over the duration
of each study, the effective dose of 0.007 and 0.03 mSv
will be administered, respectively, for both the cross-
sectional study and the 10-month study.
Confidentiality
For both studies, data will be stored in the principal inves-
tigator’s ofﬁce in password-protected computer only
accessible to members of our research team. Within the
electronic database, participants’ names will be replaced
with numeric identity codes. Blood samples will also be
labelled with the numeric identity codes and samples will
be stored in our laboratories. Only aggregate results will
be reported, ensuring participants’ anonymity.
Dissemination
The results of both studies will be disseminated at
several research conferences and published articles in
peer-reviewed journals.
DISCUSSION
The ADIBOX protocol has been developed to advance
the understanding of the bone adipocyte cross-talk in
adolescents and to extend what is currently known
about growth-related and body mass changes that may
or may not inﬂuence obesity. The speciﬁc effects of
weight loss on bone tissue are uncertain, particularly in
young people. Growth responses cannot be overlooked.
Targeting puberty stages should help to highlight
growth-stimulated responses which are often masked by
assessing young participants across puberty ranges.
Adolescence is a very sensitive period, determined by
positive and/or negative inﬂuences that may contribute
or adversely alter adolescents’ health. Despite the well-
described regular exercise-induced beneﬁts in terms of
health improvement and maintenance, adolescence is
characterised by a marked decline of physical activity
level in men and women.
The ADIBOX protocol will attempt to clarify the
impact of the bone adipocyte interaction in obese ado-
lescents and should provide a better understanding
about the bone strength indices and adiposity cross-talk
in adolescent men and women. In addition, this will be
the ﬁrst protocol investigating the effects of physical
activity-induced weight loss on bone, growth and adipos-
ity markers. Findings from this protocol are expected to
clarify the possible interactions between adiposity and
bone in childhood obesity.
Current study status
The ADIBOX protocol began recruiting participants in
September 2015. Data collection will be completed in
January 2017. Regarding the longitudinal study, data col-
lection started in September 2015 and will be running
for 10 months.
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